Pennine Acute Hospitals NHS Trust shortlisted for coveted HSJ Award
The Research and Development (R&D) team at The Pennine Acute Hospitals NHS Trust has been shortlisted for a highly coveted Health Service Journal (HSJ) Award.
The team have become finalists in the Clinical Research Impact category in the HSJ Awards 2014, after beating off fierce competition nationally to be shortlisted from a record 1300 entries, the highest ever in the awards history.
The Trust is committed to clinical research as a driver for improving the quality of care provided to patients. It enables staff and the wider NHS, nationally and regionally, to improve the current and future health of the people we serve. Only by carrying out research into “what works” can we continually improve treatment for patients, and understand how to focus NHS resources where they will be most effective.
The Trust has invested and put in place a five year strategy to achieve a 10% increase in patients being recruited to Research and Development studies year on year. In year one this was smashed with a 75% increase.
Last year, the team (pictured) recruited the first three patients in Europe to a randomised placebo-controlled clinical pain relief disease study for Parkinson’s Disease. More recently they have recruited the first patient in the UK to a new study on heart failure medication, which is looking at creating a brand new medicine to help heart failure patients.
Cancer research has also increased this year with 405 of the Trust’s patients diagnosed with cancer participating in a high quality NIHR CRN study. This level of participation in cancer research means that approximately one out of every four of the Trust’s patients diagnosed with cancer took part in a high quality study.
The Trust’s level of research within paediatrics, diabetes and cardiovascular have also grown considerably as well this year. During 2011/12 only 11 children participated in a high quality paediatric research study, whereas this year 170 children participated in a high quality study. In total 120 patients participated in a high quality diabetes study, and 180 patients participated in a cardiovascular research study.
Dr Steve Woby, director of research and development at The Pennine Acute Trust said:
“Over the past year we have worked incredibly hard to deliver a number of key initiatives aimed at integrating research into the core NHS business of the Trust and ensuring that we provide research opportunities for as many of our patients as possible. We are extremely proud of what we have accomplished and feel absolutely delighted and honoured at being shortlisted for the highly coveted HSJ Award for Clinical Research Impact.”
The HSJ Awards 2014 will take place on 19 November 2014 at Grosvenor House, London. The awards were created in 1981 to recognise, on a national platform, the projects and initiatives that deliver healthcare excellence and innovation.